Valuation (93%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 7.75 | 11.26 |
PEG Ratio (TTM) | 0.32 | 0.99 |
P/S Ratio (TTM) | 1.59 | 2.92 |
P/B Ratio (TTM) | 1.01 | 1.61 |
P/FCF Ratio (TTM) | 4.03 | 9.79 |
Price to 5YR AVG Earnings Ratio | 9.03 | 13.43 |
Price to 5YR AVG FCF Ratio | 4.66 | 6.66 |
Profitability (45%) |
Company | Industry |
---|---|---|
ROA (TTM) | 1.22% | 1.27% |
ROE (TTM) | 13.90% | 9.49% |
Net Profit Margin (TTM) | 20.30% | 20.32% |
ROIC 5YR AVG | 11.72% | 19.93% |
Growth (60%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 1.14% | 17.55% | 12.19% |
Revenue | 9.40% | 22.53% | 25.33% |
Net Income | 1.07% | 20.48% | 12.46% |
Cash Flow | 4.34% | -24.01% | -15.80% |
Health (46%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.07 | 3.77 |
Quick Ratio (TTM) | 0.32 | 7.51 |
D/E Ratio (TTM) | 0.65 | 1.31 |
Interest Coverage (TTM) | 1.27 | 0.84 |
Piotroski F-Score | 7 | 6 |
Altman Z-Score | N/A | 0.46 |
LTL to 5YR AVG FCF | 2.35 | 3.77 |
Shares Outstanding Growth 5YR AVG | 1.08% | 8.70% |